Topics

vaccine dynamics

 

Vaccine dynamics is the study of how vaccination strategies and behaviors interact with the spread of infections diseases within a population.  

Biodistribution is a method of tracking where compounds of interest travel and where they are retained in the organs and tissues of an experimental animal or human subject receiving a vaccine; the biodistribution of a vaccine.

vaccines
2.4 Nonclinical Overview AZD1222
2.5 Clinical Overview: AZD1222 Marketing Authorisation Application - Primary Analysis (Data Cut-off 07 December 2020)
A cautionary note: Toxicity of polyethylene glycol 200 injected intraperitoneally into mice
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR)
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Assessment report: COVID-19 Vaccine Moderna
Cationic compounds used in lipoplexes and polyplexes for gene delivery
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.
Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria
First case of postmortem study in a patient vaccinated against SARS-CoV-2
Form S-1 Registration Statement Under the Securities Act of 1933: BioNTech SE
Form S-1 Registration Statement Under the Securities Act of 1933: Moderna, Inc.
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
Graphene and graphene oxide as nanomaterials for medicine and biology application
Graphene and the Immune System: A Romance of Many Dimensions
How Bad is My Batch? Batch codes and associated deaths, disabilities and illnesses for Covid 19 Vaccines
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
Long Term Follow-Up After Administration of Human Gene Therapy Products Guidance for Industry
mRNA Platform: Enabling Drug Discovery & Development
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Potential adverse effects of nanoparticles on the reproductive system
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statistics
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells
Session 86 of the Corona Investigative Committee
Statement by Dr. Richard Urso
Statement by Professor Christian Perronne at Parliamentary Hearing in Luxemburg
Testimony of Dr. Aditi Bhargava
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
The EMA covid-19 data leak, and what it tells us about mRNA instability
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
Toxicity of cationic lipids and cationic polymers in gene delivery
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns
Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
1471